Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

TRANSDERM SCOP

SCOPOLAMINE

Standard Dose
1MG/72HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview TRANSDERM SCOP is listed in Drugs@FDA under application 017874 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient SCOPOLAMINE Form and strength SYSTEM;TRANSDERMAL - 1MG/72HR Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-06-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRANSDERM SCOP is listed in Drugs@FDA under application 017874 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient SCOPOLAMINE Form and strength SYSTEM;TRANSDERMAL - 1MG/72HR Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-06-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.